With patient support programs providing a number of benefits for private plan stakeholders, ongoing digitization is likely to allow even greater connectivity and personalization for patients, physicians and payers in the near future. During a panel exploring these initiatives at Benefits Canada‘s Face to Face Drug Plan Management Forum in Toronto on Dec. 5, Sandra Anderson, vice-president of […]
As plan sponsors and private payers begin integrating medical cannabis coverage into benefits plans, it’s crucial they account for the dynamic nature of the industry and remain adaptable to anticipated changes around distribution and product innovation. Although medical cannabis isn’t new, current offerings are just a first step, said Matt Gaudry, director of product support and management at […]
Pharmacogenetic testing can produce significant results for plan members, but it isn’t appropriate for everyone and should never be looked at in isolation, according to a panel discussion at Benefits Canada‘s Face to Face Drug Plan Management Forum. Speaking on the panel in Toronto on Dec. 5, Mark Faiz, chief executive officer of Personalized Prescribing Inc., said […]
Trends, benefits fraud and drug coverage led the top health and benefits stories in 2018. Benefits Canada rounds up the industry’s favourite health and benefits stories of the year: 1. Seven benefits trends to watch in 2018 2. Ontario unveils new drug, dental coverage for people without workplace benefits 3. TTC fraud update: More than 220 employees fired or have resigned, retired […]
While a national pharmacare program in Canada could mean reduced expenditures and drug prices, there could also be unintended consequences, according to a new report by the Fraser Institute. Shining a light on the national programs in Australia, New Zealand and U.K., the report looked at the cost-saving mechanisms they use, as well as the side-effects. Specifically, it noted the programs […]
With 44 per cent of Canadian workers experiencing mental-health issues and mental health the fastest growing and leading cause of disability claims, benefits plans are feeling the strain. “The numbers are staggering in terms of what we’re seeing and the continual growth of this as an issue,” said Rebecca Smith, director of group life and […]
The Canadian Life and Health Insurance Association is asking the Ontario government to act cautiously in welcoming private label products under the provincial drug program and allowing them to be interchangeable with other products. Presently, the Ontario Drug Benefit Act doesn’t list private label products as drug products, meaning they’re not eligible for public funding under the drug benefit program. […]
In its 2018 budget, the federal government created an advisory council on the implementation of national pharmacare, led by former Ontario health minister Eric Hoskins. The council, which solicited submissions from Canadians between June and September, is expected to release its final report in the spring. Whatever the report recommends, Canada is closer to a […]
Spending on prescription drugs is expected to total $33.7 billion in 2018, according to a new report by the Canadian Institute for Health Information. Of that total, $19.3 billion will come from private insurance and individuals paying out of pocket, while the remaining $14.4 billion will be financed by the public sector. As a whole, drug spending […]
Some 731,000 Canadians borrow money to pay for drugs prescribed by their doctors, according to new research by the University of British Columbia. The research, which used data from a 2016 Statistics Canada survey, found 2.5 per cent of respondents said they have to borrow money for prescriptions. Canadians between the ages of 19 and 34 were 3.5-times […]